Xi indicated that EGCG treatment significantly reduced serum calcium, urinary calcium, body weight, and body fat in mice with secondary osteoporosis, increases leptin levels, and significantly reduces alkaline phosphatase activity (Xi et al., 2018). The gene discussed is LEP; the disease is osteoporosis.